BridgeBio Oncology Therapeutics, Inc. (BBOT)

NASDAQ: BBOT · Real-Time Price · USD

9.98

-0.14 (-1.38%)

At close: Feb 20, 2026, 4:00 PM EST

10.17

+0.19 (1.90%)

After-hours: Feb 20, 2026, 4:31 PM EST

BBOT Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Selling, General & Admin	21.63	7.76	8.49
Research & Development	102.67	73.11	56.29
Operating Expenses	124.29	80.86	64.77
Operating Income	-124.29	-80.86	-64.77
Interest & Investment Income	9.05	6.38	0.07
Other Non Operating Income (Expenses)	0.3	0.21	-
Pretax Income	-114.93	-74.28	-64.7
Net Income	-114.93	-74.28	-64.7
Net Income to Common	-114.93	-74.28	-64.7
Shares Outstanding (Basic)	11	0	0
Shares Outstanding (Diluted)	11	0	0
Shares Change (YoY)	8840.04%	16.36%	-
EPS (Basic)	-10.31	-511.80	-518.73
EPS (Diluted)	-10.31	-511.80	-518.73
Free Cash Flow	-87.24	-55.08	-52.49
Free Cash Flow Per Share	-7.82	-379.51	-420.87
EBITDA	-124.04	-80.66	-64.68
D&A For EBITDA	0.25	0.21	0.09
EBIT	-124.29	-80.86	-64.77

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.